Peru's Superintendence of Banking, Insurance and Private Pension Funds (SBS) has published its Financial System Stability Report to May 2025, reporting a recovery in credit growth and an improvement in portfolio quality alongside robust solvency in the Peruvian financial system. As of March 2025, the total loan portfolio grew 1.2%, with corporate and large enterprise lending up 6.9% and mortgages up 5.4%. The system’s average capital ratio stood at 16.8%, while provisions amounted to PEN 4,208 million, covering 108.8% of the high-risk portfolio. High-risk portfolio indicators have improved since June 2024, and the high-risk ratio for total loans excluding government programmes fell to 5.9% from 6.9% in March 2024, although it remains above the 5.0% recorded in February 2020. Annualised profits increased to PEN 12,318 million, attributed mainly to lower provisioning expense and lower financial expenses, and the average instalment-to-income ratio declined to 27.0% in December 2024 from 29.4% in December 2023. Solvency stress tests indicate that under adverse macroeconomic shocks the system-wide capital ratio would decline from 16.8% in March 2025 to 13.9% in March 2027, remaining above the 10% regulatory requirement. A one-year liquidity stress test shows institutions can generally meet stressed outflows in mild and adverse scenarios, while in a severely adverse scenario the liquidity shortfall would be 0.6% of system liabilities.
Superintendencia de Banca, Seguros y AFP del Peru 2025-05-27
Peru's Superintendence of Banking, Insurance and Private Pension Funds publishes May 2025 financial stability report showing improving credit growth and asset quality
Peru's Superintendence of Banking, Insurance and Private Pension Funds (SBS) reports a recovery in credit growth and improved portfolio quality in its Financial System Stability Report to May 2025. The total loan portfolio grew by 1.2% as of March 2025, with a robust average capital ratio of 16.8%. Stress tests indicate the system's resilience, with capital ratios remaining above regulatory requirements even under adverse scenarios.